JACKSON CENTER, PA / ACCESSWIRE / September 27, 2022 / Halberd Corporation (OTC PINK:HALB) entered into a strategic alliance with AI Longevity, Inc. and Stem of Hope to form a strategic alliance as a ...

Halberd's patent position insured high potential of technical and market success. Halberd chose neurodegenerative diseases as its primary focus, since there are approximately 36 million people ...

In this video, I restore a Halberd Axe over a span of 15 days, utilizing a $2 axe and $25 worth of epoxy resin. #Halberd #Axe #Restoration Iran live updates: Iran's internet blackout partially lifted ...

Mississippi State University (MSU) is well on their way in testing Halberd's patent-pending nasal spray to mitigate the neurological effects resulting from traumatic brain injuries (TBI). By directly ...

A Major Step Towards the Elimination of Multiple Infectious Diseases and Possible Treatment for Alzheimer's Disease/PTSD/CTE Felder continued, "Our method envisions utilizing a dialysis variation in ...

JACKSON CENTER, PA / ACCESSWIRE / October 18, 2022 / Halberd Corporation (OTC PINK:HALB) has successfully eliminated various antibiotic resistant bacteria from buffer solution in-vitro through the use ...

JACKSON CENTER, PA / ACCESSWIRE / April 30, 2024 / Halberd Corporation (OTC PINK:HALB) announced a pre-pilot study of its patented LDN+ drug with military volunteers has now begun with limited ...

This video showcases the complete project of forging a beautiful halberd inspired by the medieval age. It details the ...